Literature DB >> 2011403

Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation.

P A Wright1, E D Williams, N R Lemoine, D Wynford-Thomas.   

Abstract

Activated ras oncogenes in experimentally induced rodent tumours have been demonstrated to show specific patterns of oncogene activation which depend on the inducing agent, with H-ras activation in nitrosomethylurea (NMU) induced tumours, and K-ras activation in tumours induced by ionising radiation. We report a study of 12 radiation-associated human thyroid tumours, using polymerase chain reaction (PCR) amplification of paraffin-embedded material and allele-specific hybridisation with mutant-specific probes for the 3 ras oncogenes. Compared to 68 'spontaneous' human thyroid tumours, the radiation-associated cases show the same overall prevalence of ras mutation. However there is a significantly higher rate of K-ras mutation in radiation-associated follicular carcinomas than in 'spontaneous' follicular carcinomas (60% compared to 6%, P less than 0.05), suggesting that radiation may preferentially activate K-ras in human as well as rodent tumours.

Entities:  

Mesh:

Year:  1991        PMID: 2011403

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

2.  Ras mutations are uncommon in sporadic thyroid cancer in children and young adults.

Authors:  C Fenton; J Anderson; Y Lukes; C A Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

3.  Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis.

Authors:  J A Du Villard; M Schlumberger; R Wicker; B Caillou; P Rochefort; J Feunteun; R Monier; C Parmentier; H G Suarez
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

Review 4.  Oncogenes and anti-oncogenes in human epithelial thyroid tumors.

Authors:  S Said; M Schlumberger; H G Suarez
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

5.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Ki-ras mutational analysis in rat follicular-cell proliferative lesions of the thyroid gland induced by radioactive iodine and potassium perchlorate.

Authors:  J M Fernández-Santos; M De-Miguel; R González-Cámpora; M Salguero-Villadiego; J J Cabrera; H Galera-Davidson
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

7.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.

Authors:  B Suchy; V Waldmann; S Klugbauer; H M Rabes
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

9.  Gene rearrangement and Chernobyl related thyroid cancers.

Authors:  M Santoro; G A Thomas; G Vecchio; G H Williams; A Fusco; G Chiappetta; V Pozcharskaya; T I Bogdanova; E P Demidchik; E D Cherstvoy; L Voscoboinik; N D Tronko; A Carss; H Bunnell; M Tonnachera; J Parma; J E Dumont; G Keller; H Höfler; E D Williams
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 10.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.